Skip to content

Effects of Probiotic supplementation associated with Tube Feeding on Infections and Blood Sugar control of patients in intensive care unit

Effects of Probiotics supplementation associated with Enteral Nutrition on Infectious Complications and Glucid Metabolism of patients in intensive care: a prospective, randomized, placebo-controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2kqnj2t
Enrollment
Unknown
Registered
2023-08-24
Start date
2023-05-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteral Nutrition

Interventions

The study will be Uniblind. The expected number of participants is 117 patients, 58 in the intervention group and 59 in the control group. Individuals who are going to start nutrition by gastric or en
G07.203.300.456.500

Sponsors

Universidade Federal do Paraná
Lead Sponsor
Pontifícia Universidade Católica do Paraná
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ndividuals of both sexes; aged 18 years or older; who are hospitalized in an intensive care unit; who have indication of enteral nutrition via nasogastric, nasoenteral or gastrostomy tube will be included

Exclusion criteria

Exclusion criteria: Individuals who do not present hemodynamic conditions to receive enteral diet, patients with lesions in the gastrointestinal tract that make it impossible to receive enteral diet, patients who are in palliative treatment, who undergo immunosuppressive treatment, who have heart valve prosthesis or valve graft, who have a history of endocarditis, history of rheumatic fever, recent postoperative period of intestinal anastomosis, biliary tract and pancreas surgery, intestinal ischemia, patients with hematological and rheumatological diseases, as recommended by the 2018 Brazilian guideline for nutritional therapy in critically ill patients (BRASPEN, 2018)

Design outcomes

Primary

MeasureTime frame
It is expected to find a reduction in the number of infections occurring within the ICU for patients who use probiotics associated with enteral nutrition compared to the control group, observed by the percentage difference in the number of infections that will occur in the research participants

Secondary

MeasureTime frame
It is expected to find a reduction in capillary glycemia in patients who use probiotics associated with enteral nutrition compared to the control group, observed by the percentage difference in insulin use to patients. ;It is expected to find a reduction in the length of stay in the ICU for patients receiving probiotics compared to the control group, observed by the difference in the number of days they are hospitalized in the intensive care unit;It is expected to find a reduction in the duration of mechanical ventilation in patients receiving probiotics compared to the control group, observed by the difference in the number of days they are on mechanical ventilation

Countries

Brazil

Contacts

Public ContactJanaina Pocidoni

Universidade Federal do Paraná

janainanaslowski@gmail.com+5541995627376

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 5, 2026